Back to Search
Start Over
Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson's disease
- Source :
- NPJ Parkinson's Disease; 2; 2373-8057; vol. 3; ~NPJ Parkinson's Disease~2~~~~2373-8057~~3~~
- Publication Year :
- 2017
-
Abstract
- Contains fulltext : 176019.pdf (publisher's version ) (Open Access)<br />The progressive nature of Parkinson's disease, its complex treatment regimens and the high rates of comorbid conditions make self-management and treatment adherence a challenge. Clinicians have limited face-to-face consultation time with Parkinson's disease patients, making it difficult to comprehensively address non-adherence. Here we share the results from a multi-centre (seven centres) randomised controlled trial conducted in England and Scotland to assess the impact of using a smartphone-based Parkinson's tracker app to promote patient self-management, enhance treatment adherence and quality of clinical consultation. Eligible Parkinson's disease patients were randomised using a 1:1 ratio according to a computer-generated random sequence, stratified by centre and using blocks of variable size, to intervention Parkinson's Tracker App or control (Treatment as Usual). Primary outcome was the self-reported score of adherence to treatment (Morisky medication adherence scale -8) at 16 weeks. Secondary outcomes were Quality of Life (Parkinson's disease questionnaire -39), quality of consultation for Parkinson's disease patients (Patient-centred questionnaire for Parkinson's disease), impact on non-motor symptoms (Non-motor symptoms questionnaire), depression and anxiety (Hospital anxiety and depression scale) and beliefs about medication (Beliefs about Medication Questionnaire) at 16 weeks. Primary and secondary endpoints were analysed using a generalised linear model with treatment as the fixed effect and baseline measurement as the covariate. 158 patients completed the study (Parkinson's tracker app = 68 and TAU = 90). At 16 weeks Parkinson's tracker app significantly improved adherence, compared to treatment as usual (mean difference: 0.39, 95%CI 0.04-0.74; p = 0.0304) with no confounding effects of gender, number of comorbidities and age. Among secondary outcomes, Parkinson's tracker app significantly improved patients' perception of quality of consultation (0.15, 9
Details
- Database :
- OAIster
- Journal :
- NPJ Parkinson's Disease; 2; 2373-8057; vol. 3; ~NPJ Parkinson's Disease~2~~~~2373-8057~~3~~
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1284042502
- Document Type :
- Electronic Resource